Shorter disease-free survival (DFS) was associated with Glut-1 positivity (P = 0.010), BNIP3 negativity, tumor phenotype (HER2 and TNBC; P < 0.001) and tumor metabolic type (reverse Warburg type; P = 0.037) (Figure 2). The gene discussed is SLC2A1; the disease is neoplasm.